Nasdaq · CIK 0001386301
RSSS Research Solutions, Inc.
Insider trading from SEC Form 4. Last filing May 6, 2026.
Research Solutions, Inc. (RSSS) has 28 SEC Form 4 filings on file from 10 insiders, the latest filed on May 6, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Research Solutions, Inc., scored.
Transactions
Every row filed, 37 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Sefton Cohen Chief Revenue Officer | AGrant or award Common Stock | +80,000 | $2.29 | $183k | 359,933 | May 6, 2026 |
| Dec 10, 2025 | David Kutil CFO & Secretary | AGrant or award Common Stock | +30,000 | $3.00 | $90k | 30,000 | Dec 22, 2025 |
| Dec 19, 2025 | David Kutil CFO & Secretary | FTax withholding Common Stock | -758 | $2.89 | $2,191 | 29,242 | Dec 22, 2025 |
| Nov 12, 2025 | Kenneth L Gayron director | AGrant or award Option to purchase common stockderivative | +50,000 | $0.00 | $0 | 50,000 | Dec 16, 2025 |
| Nov 12, 2025 | Merrill A McPeak director | MOption exercise Common Stock | +75,000 | $0.70 | $53k | 484,608 | Dec 12, 2025 |
| Nov 12, 2025 | Merrill A McPeak director | AGrant or award Option to purchase common stockderivative | +50,000 | $0.00 | $0 | 50,000 | Dec 12, 2025 |
| Nov 12, 2025 | Merrill A McPeak director | MOption exercise Option to purchase common stockderivative | -75,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Nov 17, 2025 | John J Regazzi director | MOption exercise Common Stock | +150,000 | $0.70 | $105k | 318,500 | Nov 21, 2025 |
| Nov 12, 2025 | John J Regazzi director | AGrant or award Option to purchase common stockderivative | +60,000 | $0.00 | $0 | 60,000 | Nov 21, 2025 |
| Nov 17, 2025 | John J Regazzi director | MOption exercise Option to purchase common stockderivative | -150,000 | $0.00 | $0 | 0 | Nov 21, 2025 |
| Nov 12, 2025 | Barbara J. Cooperman director | AGrant or award Option to purchase common stockderivative | +50,000 | $0.00 | $0 | 50,000 | Nov 14, 2025 |
| Nov 12, 2025 | Jeremy Murphy director | AGrant or award Option to purchase common stockderivative | +50,000 | $0.00 | $0 | 50,000 | Nov 14, 2025 |
| Sep 19, 2025 | William Nurthen CFO & Secretary | FTax withholding Common Stock | -2,225 | $3.66 | $8,144 | 378,382 | Sep 26, 2025 |
| Sep 19, 2025 | Roy W Olivier CEO & President | FTax withholding Common Stock | -1,428 | $3.66 | $5,226 | 606,825 | Sep 26, 2025 |
| Jun 20, 2025 | Scott Ahlberg Chief Operating Officer | FTax withholding Common Stock | -933 | $2.69 | $2,510 | 543,549 | Jun 23, 2025 |
| Jun 20, 2025 | William Nurthen CFO & Secretary | FTax withholding Common Stock | -2,909 | $2.69 | $7,825 | 380,607 | Jun 23, 2025 |
| Jun 20, 2025 | Roy W Olivier CEO & President | FTax withholding Common Stock | -2,126 | $2.69 | $5,719 | 608,253 | Jun 23, 2025 |
| Jun 18, 2025 | Merrill A McPeak director | MOption exercise Common Stock | +75,000 | $1.10 | $83k | 409,608 | Jun 18, 2025 |
| Jun 18, 2025 | Merrill A McPeak director | MOption exercise Option to purchase common stockderivative | -75,000 | $0.00 | $0 | 0 | Jun 18, 2025 |
| Jun 5, 2025 | John J Regazzi director | MOption exercise Common Stock | +30,000 | $1.10 | $33k | 152,500 | Jun 6, 2025 |
| Jun 5, 2025 | John J Regazzi director | MOption exercise Common Stock | +16,000 | $0.80 | $13k | 168,500 | Jun 6, 2025 |
| Jun 5, 2025 | John J Regazzi director | MOption exercise Option to purchase common stockderivative | -30,000 | $0.00 | $0 | 0 | Jun 6, 2025 |
| Jun 5, 2025 | John J Regazzi director | MOption exercise Option to purchase common stockderivative | -16,000 | $0.00 | $0 | 0 | Jun 6, 2025 |
| May 2, 2025 | Merrill A McPeak director | MOption exercise Common Stock | +50,000 | $1.05 | $53k | 334,608 | Jun 4, 2025 |
| May 2, 2025 | Merrill A McPeak director | MOption exercise Option to purchase common stockderivative | -50,000 | $0.00 | $0 | 0 | Jun 4, 2025 |
| Mar 20, 2025 | Scott Ahlberg Chief Operating Officer | FTax withholding Common Stock | -21,980 | $2.85 | $63k | 544,482 | Mar 21, 2025 |
| Mar 20, 2025 | Sefton Cohen Chief Revenue Officer | FTax withholding Common Stock | -35,086 | $2.85 | $100k | 279,933 | Mar 21, 2025 |
| Dec 20, 2024 | Sefton Cohen Chief Revenue Officer | FTax withholding Common Stock | -24,981 | $3.93 | $98k | 315,019 | Dec 23, 2024 |
| Dec 20, 2024 | Roy W Olivier CEO & President | FTax withholding Common Stock | -1,986 | $3.93 | $7,805 | 654,847 | Dec 23, 2024 |
| Dec 20, 2024 | William Nurthen CFO & Secretary | FTax withholding Common Stock | -2,204 | $3.93 | $8,662 | 425,204 | Dec 23, 2024 |
| Dec 20, 2024 | Scott Ahlberg Chief Operating Officer | FTax withholding Common Stock | -919 | $3.93 | $3,612 | 566,462 | Dec 23, 2024 |
| Nov 12, 2024 | Sefton Cohen Chief Revenue Officer | AGrant or award Common Stock | +340,000 | $0.00 | $0 | 340,000 | Nov 14, 2024 |
| Nov 12, 2024 | Barbara J. Cooperman director | AGrant or award Option to purchase common stockderivative | +50,000 | $0.00 | $0 | 50,000 | Nov 13, 2024 |
| Nov 12, 2024 | Kenneth L Gayron director | AGrant or award Option to purchase common stockderivative | +50,000 | $0.00 | $0 | 50,000 | Nov 13, 2024 |
| Nov 12, 2024 | Merrill A McPeak director | AGrant or award Option to purchase common stockderivative | +50,000 | $0.00 | $0 | 50,000 | Nov 13, 2024 |
| Nov 12, 2024 | Jeremy Murphy director | AGrant or award Option to purchase common stockderivative | +50,000 | $0.00 | $0 | 50,000 | Nov 13, 2024 |
| Nov 12, 2024 | John J Regazzi director | AGrant or award Option to purchase common stockderivative | +60,000 | $0.00 | $0 | 60,000 | Nov 13, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Scott AhlbergChief Operating Officer
- Sefton CohenChief Revenue Officer
- Barbara J. Coopermandirector
- Kenneth L Gayrondirector
- David KutilCFO & Secretary
- Merrill A McPeakdirector
- Jeremy Murphydirector
- William NurthenCFO & Secretary
- Roy W OlivierCEO & President
- John J Regazzidirector
Questions about RSSS
Answered from the filings on this page, as of the latest one.
Are insiders buying RSSS?
No. In the last 90 days no insider at Research Solutions, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade RSSS on the open market?
No open-market trade has been scored at Research Solutions, Inc.. The latest Form 4 on file was filed on May 6, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Research Solutions, Inc.?
10 people have filed a Form 4 at Research Solutions, Inc., among them Scott Ahlberg (Chief Operating Officer), Sefton Cohen (Chief Revenue Officer), Barbara J. Cooperman (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.